These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32740213)

  • 1. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
    Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
    Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey.
    Siscos SM; Neill BC; Seger EW; Rajpara A; Hocker TLH
    J Am Acad Dermatol; 2021 Mar; 84(3):833-835. PubMed ID: 33022309
    [No Abstract]   [Full Text] [Related]  

  • 3. Mohs Micrographic Surgery for the Treatment of Melanoma: A Cross-Sectional Survey on the Barriers, Prevalence, and Practice.
    Orfaly VE; Hagstrom EL; Leitenberger JJ; Latour E; Bar A
    Dermatol Surg; 2021 Aug; 47(8):1114-1115. PubMed ID: 33587372
    [No Abstract]   [Full Text] [Related]  

  • 4. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
    Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
    J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
    Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
    J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mohs micrographic surgery for melanoma: A prospective multicenter study.
    Ellison PM; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
    Stigall LE; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization Patterns of Fellowship-Trained Mohs Surgeons in the Treatment of Melanoma in Situ and Melanoma.
    Barklund JS; Cameron MC; Mirhossaini RB; Brown M
    Dermatol Surg; 2021 Jun; 47(6):814-815. PubMed ID: 32932262
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors Deterring the Utilization of Mohs Surgery for Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
    Siscos SM; Neill BC; Seger EW; Hocker TLH
    Dermatol Surg; 2021 May; 47(5):709-710. PubMed ID: 33905398
    [No Abstract]   [Full Text] [Related]  

  • 10. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
    Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
    Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
    Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
    Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
    Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
    JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing General Dermatologists When Referring Patients With Head and Neck Melanoma for Mohs Micrographic Surgery: A Nationwide Cross-Sectional Survey.
    Neill BC; Siscos SM; Bar AA; Seger EW; Latour E; Tolkachjov SN
    Dermatol Surg; 2023 May; 49(5):451-455. PubMed ID: 36989088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management.
    Levoska MA; Schmults CD; Waldman AH
    Arch Dermatol Res; 2020 Dec; 312(10):753-756. PubMed ID: 32002653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies.
    Shah P; Trepanowski N; Grant-Kels JM; LeBoeuf M
    J Am Acad Dermatol; 2024 Sep; 91(3):499-507. PubMed ID: 38768857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas.
    Shin TM; Nugent S; Aizman L; Weiner DM; O'Malley V; Sobanko JF; Etzkorn JR; Chu EY; Elenitsas R; Giordano CN; Higgins Ii HW; Miller CJ
    J Am Acad Dermatol; 2021 Jan; 84(1):196-198. PubMed ID: 32339704
    [No Abstract]   [Full Text] [Related]  

  • 17. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
    Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
    J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution.
    Krishnan A; Xu T; Hutfless S; Park A; Stasko T; Vidimos AT; Leshin B; Coldiron BM; Bennett RG; Marks VJ; Brandt R; Makary MA; Albertini JG;
    JAMA Dermatol; 2017 Jun; 153(6):565-570. PubMed ID: 28453605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail Unit Melanoma In Situ Treated With Mohs Micrographic Surgery.
    Matsumoto A; Strickland N; Nijhawan RI; Srivastava D
    Dermatol Surg; 2021 Jan; 47(1):98-103. PubMed ID: 32796325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
    Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
    Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.